RL
Therapeutic Areas
OssiFi Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Sclerostin Small Molecule Inhibitor | Neurogenic Low Back Pain, Fracture Repair, Fracture Prevention/Osteoporosis | Pre-clinical |
| Smart Tissue Scaffold | Bone Repair (Device) | Product Development |
Leadership Team at OssiFi Therapeutics
DL
Debra L. Ellies, Ph.D.
CEO & Chairwoman
FS
F. Scott Kimball, Ph.D.
Head of Discovery
SP
Steven Peckham, Ph.D.
Product Development, Smart Tissue Scaffold
RP
Randall Pratt, J.D.
Counsel
NS
Niels Svenstrup, Ph.D.
Product Development, Osteoporosis